Key result
A 22-year-old man with laryngeal synovial sarcoma treated with neoadjuvant chemotherapy, total laryngectomy, and adjuvant radiotherapy remained recurrence-free at 12 months of follow-up.
Why the study?
Laryngeal synovial sarcoma is exceptionally rare, and reporting such cases may improve future diagnosis, evaluation, and management of this entity.
Population
One 22-year-old man with laryngeal synovial sarcoma
Design
Case report and review of the literature
Follow-up
12 months
Authors
Loading...
Alerts clinicians to rare laryngeal tumors in young adults with hoarseness; leaves open evidence-based management strategies.
Case Report (n=1)
Laryngeal synovial sarcoma is a rare malignancy that can present with hemoptysis and may be successfully managed with a multimodal approach including surgery, chemotherapy, and radiotherapy.
Iravani et al. (2026) conducted a case report in Laryngeal Synovial Sarcoma (n=1). Neoadjuvant chemotherapy, total laryngectomy, and adjuvant radiotherapy was evaluated on Recurrence. A 22-year-old man with laryngeal synovial sarcoma treated with neoadjuvant chemotherapy, total laryngectomy, and adjuvant radiotherapy remained recurrence-free at 12 months of follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: